Oncology & Cancer

High doses of saw palmetto don't impact serum PSA

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research published in ...

Diseases, Conditions, Syndromes

Bacteria in urine doesn't always indicate infection

Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released ...

Diseases, Conditions, Syndromes

High doses of saw palmetto appear safe over 18 months

(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

Diseases, Conditions, Syndromes

Overactive bladder common in postacute COVID-19 syndrome

Overactive bladder (OAB) symptoms are common in patients recovering from postacute COVID-19 syndrome (PACS), according to a study published online Oct. 26 in the Journal of Multidisciplinary Healthcare.

Medications

Popular prostate drug linked to serious side effects

Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening ...

Health informatics

Machine learning goes with the flow

An artificial intelligence (AI) algorithm trained to listen to patients pass urine is able to identify abnormal flows and could be a useful and cost-effective means of monitoring and managing urology patients at home. It ...

page 2 from 7